ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

174 Epizód

1. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Return to Play

   Közzétéve: 2022. 07. 05.
2. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Post-acute Sequelae

   Közzétéve: 2022. 06. 28.
3. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Myocarditis

   Közzétéve: 2022. 06. 21.
4. ACCEL Lite: Inflamed! Populations at Risk for Inflammation Associated CVD

   Közzétéve: 2022. 06. 14.
5. ACCEL Lite: Significant Updates from the 2021 ACC Coronary Artery Revascularization Guidelines

   Közzétéve: 2022. 06. 07.
6. ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR

   Közzétéve: 2022. 05. 24.
7. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

   Közzétéve: 2022. 05. 17.
8. ACCEL Lite: ACC.22 Late Breaker: CHAP RCT -- Antihypertensive Therapy For Mild Chronic Hypertension Improves Pregnancy Outcomes

   Közzétéve: 2022. 05. 10.
9. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

   Közzétéve: 2022. 05. 03.
10. ACCEL Lite: Late Breaker: Mavacamten as an Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Közzétéve: 2022. 04. 26.
11. ACCEL Lite: Late Breaker: SODIUM-HF: Dietary Intervention Under 100 Mmol In Heart Failure

    Közzétéve: 2022. 04. 19.
12. ACCEL Lite: Late Breaker: METEORIC-HF: The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic HFrEF

    Közzétéve: 2022. 04. 12.
13. ACCEL Lite: Late Breaker: DIAMOND trial: Patiromer For The Management Of Hyperkalemia In Subjects Receiving Renin-angiotensin-aldosterone System Inhibitor Medications For HFrEF

    Közzétéve: 2022. 04. 05.
14. ACCEL Lite: Screening for Transthretin Amyloid Cardiomyopathy in Everyday Practice

    Közzétéve: 2022. 03. 22.
15. ACCEL Lite: When Is Genetic Testing Helpful?

    Közzétéve: 2022. 03. 15.
16. ACCEL Lite: Special Considerations in Screening of Masters Athletes with CAD

    Közzétéve: 2022. 03. 08.
17. ACCEL Lite: Helping Patients Improve Lifestyle Behavior in the Digital Era

    Közzétéve: 2022. 03. 01.
18. ACCEL Lite: Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis--Focus on AL

    Közzétéve: 2022. 02. 22.
19. ACCEL Lite: What Should Optimal Medical Therapy Look Like Prior to Intervention?

    Közzétéve: 2022. 02. 15.
20. ACCEL Lite: Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL-Cholesterol

    Közzétéve: 2022. 02. 08.